Convatec Group PLC (LON:CTEC)

Market Cap	4.21B -19.9%
Revenue (ttm)	1.81B +6.6%
Net Income	130.03M -8.4%
EPS	0.06 -7.5%
Shares Out	1.95B
PE Ratio	33.71
Forward PE	14.28
Dividend	0.05 (2.51%)
Ex-Dividend Date	Apr 16, 2026

Volume	7,503,553
Average Volume	9,967,036
Open	219.20
Previous Close	218.40
Day's Range	215.00 - 221.20
52-Week Range	209.40 - 311.20
Beta	0.76
RSI	35.68
Earnings Date	Aug 4, 2026

About Convatec Group

Convatec Group PLC engages in the development, manufacturing, and sale of medical products, services and technologies for the management of chronic conditions in Europe, North America, and internationally. The company offers advanced wound care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorect...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1978
• Employees: 10,910
• Stock Exchange: London Stock Exchange
• Ticker Symbol: CTEC

Financial Performance

In 2025, Convatec Group's revenue was $2.44 billion, an increase of 6.55% compared to the previous year's $2.29 billion. Earnings were $175.00 million, a decrease of -8.38%.

Financial numbers in USD